18 phd-software-engineering-"https:" "https:" "Universidade do Minho CTAC" Fellowship positions at City of Hope
-
biology, genetics, or a closely related quantitative field. A degree in computer science is especially valuable due to the software engineering, algorithmic, and AI/ML components central to this role
-
cancer. Work in the lab utilizes both genetically engineered mouse models and in vitro systems. A combination of state-of-the-art surgical, genetic, cellular, biochemical, imaging, and metabolic flux
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages
-
. Gu’s lab and research, please visit: https://gu-lab.net and https://www.cityofhope.org/Zhaohui-Gu As a successful candidate, you will: Design and execute experiments to understand the molecular
-
: · PhD or M.D. with a strong background and profound knowledge in the field of either molecular biology, immunology, cancer biology, experience in sequencing or protein structural data analysis is highly
-
externally (e.g., conferences) Required: PhD in Bioinformatics, Computer Science, Computational Biology, or related field Experience analyzing DNA sequencing data Proficiency in Python and/or R Familiarity
-
qualifications should include: A PhD, MD or MD/PhD in molecular biology, cancer genetics, cancer biology, pathology, immunology, or a related biomedical field. Familiarity with flow cytometry, RNA/DNA analysis
-
Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
perform molecular level diagnoses for precision medicine. About Dr. Jovanovic-Talisman: Tijana Jovanovic-Talisman, PhD is an Associate Professor in the department of Cancer Biology and Molecular Medicine
-
mechanisms of macrophages in cancer immunosurveillance, identify immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering